Trademark: 88320499
Status Date
Tuesday, January 11, 2022
Registration Number
6610479
Registration Date
Tuesday, January 11, 2022
Filing Date
Thursday, February 28, 2019
Published for Opposition
Tuesday, October 26, 2021
9 (Based on 44(e)) Measuring, detecting and monitoring instruments, measuring, detecting and monitoring devices, and measuring, detecting and monitoring regulators, for preparing, processing and evaluating diagnostic samples, for detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Sensors and detectors, in particular UV fluorescence and chemiluminescence detectors for preparing, processing and evaluating diagnostic samples; Apparatus for recording, transmission and reproduction of diagnostic data, sound and images, in particular cameras, microscopes, photometers, microplate photometers, enzyme-linked immunosorbent assay readers, photomultipliers, and microplate readers; (Based on Use in Commerce) Recorded software, downloadable software, and software recorded on media, in particular laboratory software, immunofluorescence positioning software and software for evaluating diagnostic samples for the purpose of detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer
42 (Based on 44(e)) Scientific services and research, in particular scientific services for evaluating diagnostic samples for the purpose of detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Industrial analysis in the nature of analysis of industrial and medical fluids and reagents; Scientific research services, in particular research services for evaluating diagnostic samples for detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; Design and development of computer hardware and software, in particular laboratory software, immunofluorescence positioning software and software for evaluating diagnostic samples for detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer; (Based on Use in Commerce) Providing on-line non-downloadable software, namely, laboratory software, immunofluorescence positioning software and software for evaluating diagnostic samples for the purpose of detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases and cancer
Jan 11, 2022
Registered-Principal Register
Oct 26, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 26, 2021
Published For Opposition
Oct 6, 2021
Notification Of Notice Of Publication E-Mailed
Sep 20, 2021
Approved For Pub - Principal Register
Jul 13, 2021
Suspension Checked ¿ To Attorney For Action
Jun 16, 2021
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Jun 15, 2021
Use Amendment Accepted
Apr 22, 2021
Amendment To Use Processing Complete
Apr 22, 2021
Use Amendment Filed
Apr 21, 2021
Teas Amendment Of Use Received
Mar 18, 2021
Teas/Email Correspondence Entered
Mar 17, 2021
Correspondence Received In Law Office
Mar 17, 2021
Teas Response To Suspension Inquiry Received
Aug 25, 2020
Report Completed Suspension Check Case Still Suspended
Aug 6, 2020
Assigned To Lie
Jan 17, 2020
Notification Of Letter Of Suspension E-Mailed
Jan 17, 2020
Letter Of Suspension E-Mailed
Jan 17, 2020
Suspension Letter Written
Jan 17, 2020
Examiner's Amendment Entered
Jan 17, 2020
Notification Of Examiners Amendment E-Mailed
Jan 17, 2020
Examiners Amendment E-Mailed
Jan 17, 2020
Examiners Amendment -Written
Jan 6, 2020
Notification Of Letter Of Suspension E-Mailed
Jan 6, 2020
Letter Of Suspension E-Mailed
Jan 6, 2020
Suspension Letter Written
Jan 6, 2020
Examiner's Amendment Entered
Jan 6, 2020
Notification Of Examiners Amendment E-Mailed
Jan 6, 2020
Examiners Amendment E-Mailed
Jan 6, 2020
Examiners Amendment -Written
Dec 6, 2019
Notification Of Letter Of Suspension E-Mailed
Dec 6, 2019
Letter Of Suspension E-Mailed
Dec 6, 2019
Suspension Letter Written
Dec 6, 2019
Examiner's Amendment Entered
Dec 6, 2019
Notification Of Examiners Amendment E-Mailed
Dec 6, 2019
Examiners Amendment E-Mailed
Dec 6, 2019
Examiners Amendment -Written
Nov 7, 2019
Teas/Email Correspondence Entered
Nov 7, 2019
Correspondence Received In Law Office
Nov 7, 2019
Teas Response To Office Action Received
Jul 9, 2019
Assigned To Examiner
May 9, 2019
Notification Of Non-Final Action E-Mailed
May 9, 2019
Non-Final Action E-Mailed
May 9, 2019
Non-Final Action Written
May 9, 2019
Assigned To Examiner
Mar 20, 2019
New Application Office Supplied Data Entered In Tram
Mar 4, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
